| Dr Alexis C Perkins, MD | |
|
290 Baker Ave, Ste 220n, Concord, MA 01742-2189 | |
| (978) 369-9023 | |
| Not Available |
| Full Name | Dr Alexis C Perkins |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 17 Years |
| Location | 290 Baker Ave, Concord, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659547727 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 233211 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emerson Hospital - | W concord, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Associates Of Concord Inc | 6901839539 | 13 |
News Archive
The National Comprehensive Cancer Network recently announced the latest addition to the library of NCCN Guidelines for Patients, the NCCN Guidelines for Patients: Multiple Myeloma. This new resource is a patient-friendly translation of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma, which physicians use when determining appropriate cancer treatment.
Instem, a leading provider of early drug development software solutions, announced today details of their newest product line, Centrus™, for enterprise information integration in early drug development. Centrus provides a single, secure environment to access, harmonize and use early drug development information from a variety of sources, including current data acquisition systems, legacy systems, warehouses, partner and contract research applications, to meet the rapidly-expanding needs of life science organizations for data-driven decision making.
Personalized medicine - health care tailored to the individual patient - not only involves the use of prescription medications but vitamins and supplements as well.
A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia, according to a study led in part by Dana-Farber Cancer Institute investigators.
› Verified 4 days ago
| Entity Name | Dermatology Associates Of Concord Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508964230 PECOS PAC ID: 6901839539 Enrollment ID: O20050914001078 |
News Archive
The National Comprehensive Cancer Network recently announced the latest addition to the library of NCCN Guidelines for Patients, the NCCN Guidelines for Patients: Multiple Myeloma. This new resource is a patient-friendly translation of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma, which physicians use when determining appropriate cancer treatment.
Instem, a leading provider of early drug development software solutions, announced today details of their newest product line, Centrus™, for enterprise information integration in early drug development. Centrus provides a single, secure environment to access, harmonize and use early drug development information from a variety of sources, including current data acquisition systems, legacy systems, warehouses, partner and contract research applications, to meet the rapidly-expanding needs of life science organizations for data-driven decision making.
Personalized medicine - health care tailored to the individual patient - not only involves the use of prescription medications but vitamins and supplements as well.
A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia, according to a study led in part by Dana-Farber Cancer Institute investigators.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexis C Perkins, MD 290 Baker Ave, Concord, MA 01742-2189 Ph: (617) 821-4472 | Dr Alexis C Perkins, MD 290 Baker Ave, Ste 220n, Concord, MA 01742-2189 Ph: (978) 369-9023 |
News Archive
The National Comprehensive Cancer Network recently announced the latest addition to the library of NCCN Guidelines for Patients, the NCCN Guidelines for Patients: Multiple Myeloma. This new resource is a patient-friendly translation of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma, which physicians use when determining appropriate cancer treatment.
Instem, a leading provider of early drug development software solutions, announced today details of their newest product line, Centrus™, for enterprise information integration in early drug development. Centrus provides a single, secure environment to access, harmonize and use early drug development information from a variety of sources, including current data acquisition systems, legacy systems, warehouses, partner and contract research applications, to meet the rapidly-expanding needs of life science organizations for data-driven decision making.
Personalized medicine - health care tailored to the individual patient - not only involves the use of prescription medications but vitamins and supplements as well.
A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia, according to a study led in part by Dana-Farber Cancer Institute investigators.
› Verified 4 days ago
Shelley Yang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext Ste 305&306, Concord, MA 01742 Phone: 978-371-7010 Fax: 978-371-0522 | |
Dr. Terry P Hadley, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 290 Baker Ave, Concord, MA 01742 Phone: 978-369-9023 | |
Brandon Rowe, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext Ste 305&306, Concord, MA 01742 Phone: 351-300-0110 | |
Matthew T Zipoli, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 290 Baker Ave, Concord, MA 01742 Phone: 978-369-9023 Fax: 978-371-9675 | |
Dr. Peter Muz, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext 305, Concord, MA 01742 Phone: 978-371-7010 | |
David E Geist, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext Ste 305, Concord, MA 01742 Phone: 978-371-7010 | |
Caroline L Levine, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 290 Baker Ave, Concord, MA 01742 Phone: 978-369-9023 Fax: 978-371-9675 |